Uricosuric medications for chronic gout

Alison S Kydd(University of British Columbia), Claire Bombardier(Toronto General Hospital), Rachelle Buchbinder(Institute for Musculoskeletal Health), Rakhi Seth(Center for Rheumatology), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust)

Cochrane Database of Systematic Reviews

November 13, 2014

10.1002/14651858.cd010457.pub2

Cited by 67

Related Papers

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

|The Lancet|2012|12k

The american college of rheumatology 1990 criteria for the classification of fibromyalgia

|Arthritis & Rheumatism|1990|9.6k

What low back pain is and why we need to pay attention

|The Lancet|2018|4.7k

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

|New England Journal of Medicine|2000|4k

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

|Annals of the Rheumatic Diseases|2020|2.8k